Advertisement
Screener

OrthoPediatrics Corp (KIDS) General and Administrative Expense

2.8 / 5 stars · 68/120 Roast Me

OrthoPediatrics Corp General and Administrative Expense

OrthoPediatrics Corp (KIDS) reported General and Administrative Expense of $32.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:GeneralAndAdministrativeExpense · last filed 2026-08-05

  • OrthoPediatrics Corp general and administrative expense for the quarter ending 2026-06-30 was $32.81M, a 7.79% increase year-over-year.
  • OrthoPediatrics Corp general and administrative expense for the quarter ending 2026-03-31 was $31.02M, a 2.46% increase year-over-year.
  • OrthoPediatrics Corp general and administrative expense for the quarter ending 2025-12-31 was $29.95M, a 22.61% increase year-over-year.
  • OrthoPediatrics Corp general and administrative expense for the quarter ending 2025-09-30 was $29.16M, a 10.86% increase year-over-year.
  • OrthoPediatrics Corp general and administrative expense for fiscal 2025 was $119.83M, a 16.58% increase from fiscal 2024.
  • OrthoPediatrics Corp general and administrative expense for fiscal 2024 was $102.79M, a 40.23% increase from fiscal 2023.
  • OrthoPediatrics Corp general and administrative expense for fiscal 2023 was $73.30M, a 26.59% increase from fiscal 2022.
  • OrthoPediatrics Corp general and administrative expense for fiscal 2022 was $57.90M, a 25.71% increase from fiscal 2021.
Period endGeneral and Administrative Expense 3 monthGeneral and Administrative Expense 3 month as first filedGeneral and Administrative Expense 6 monthGeneral and Administrative Expense 6 month as first filedGeneral and Administrative Expense 9 monthGeneral and Administrative Expense 9 month as first filedGeneral and Administrative Expense 12 monthGeneral and Administrative Expense 12 month as first filed
2026-06-30$32.81M
10-Q · filed 2026-08-05
$63.84M
10-Q · filed 2026-08-05
$93.79M
derived: sum of 3 quarters · filed 2026-08-05
$122.95M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$31.02M
10-Q · filed 2026-05-01
$60.98M
derived: sum of 2 quarters · filed 2026-05-01
$90.13M
derived: sum of 3 quarters · filed 2026-05-01
$120.58M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$29.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$59.11M
derived: sum of 2 quarters · filed 2026-03-04
$89.55M
derived: sum of 3 quarters · filed 2026-08-05
$119.83M
10-K · filed 2026-03-04
2025-09-30$29.16M
10-Q · filed 2025-10-29
$59.60M
derived: sum of 2 quarters · filed 2026-08-05
$89.88M
10-Q · filed 2025-10-29
$114.31M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$30.44M
10-Q · filed 2026-08-05
$60.72M
10-Q · filed 2026-08-05
$85.15M
derived: sum of 3 quarters · filed 2026-08-05
$111.45M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$30.28M
10-Q · filed 2026-05-01
$54.71M
derived: sum of 2 quarters · filed 2026-05-01
$81.01M
derived: sum of 3 quarters · filed 2026-05-01
$108.34M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$24.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$50.73M
derived: sum of 2 quarters · filed 2026-03-04
$78.06M
derived: sum of 3 quarters · filed 2026-03-04
$102.79M
10-K · filed 2026-03-04
2024-09-30$26.30M
10-Q · filed 2025-10-29
$53.63M
derived: sum of 2 quarters · filed 2025-10-29
$78.36M
10-Q · filed 2025-10-29
$97.42M
derived: sum of 4 quarters · filed 2026-03-04
2024-06-30$27.33M
10-Q · filed 2025-08-06
$52.06M
10-Q · filed 2025-08-06
$71.12M
derived: sum of 3 quarters · filed 2026-03-04
$89.09M
derived: sum of 4 quarters · filed 2026-03-04
2024-03-31$24.73M
10-Q · filed 2025-05-08
$43.79M
derived: sum of 2 quarters · filed 2026-03-04
$61.76M
derived: sum of 3 quarters · filed 2026-03-04
$80.87M
derived: sum of 4 quarters · filed 2026-03-04
2023-12-31$19.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$37.03M
derived: sum of 2 quarters · filed 2026-03-04
$56.14M
derived: sum of 3 quarters · filed 2026-03-04
$73.30M
10-K · filed 2026-03-04
$75.42M
10-K · filed 2024-03-08
2023-09-30$17.97M
10-Q · filed 2024-11-07
$18.51M
10-Q · filed 2023-11-07
$37.09M
derived: sum of 2 quarters · filed 2024-11-07
$54.24M
10-Q · filed 2024-11-07
$55.83M
10-Q · filed 2023-11-07
$69.32M
derived: sum of 4 quarters · filed 2025-03-05
2023-06-30$19.11M
10-Q · filed 2024-08-06
$19.65M
10-Q · filed 2023-08-01
$36.27M
10-Q · filed 2024-08-06
$37.32M
10-Q · filed 2023-08-01
$51.34M
derived: sum of 3 quarters · filed 2025-03-05
$66.46M
derived: sum of 4 quarters · filed 2025-03-05
2023-03-31$17.16M
10-Q · filed 2024-05-07
$17.67M
10-Q · filed 2023-05-02
$32.23M
derived: sum of 2 quarters · filed 2025-03-05
$47.35M
derived: sum of 3 quarters · filed 2025-03-05
$61.89M
derived: sum of 4 quarters · filed 2025-03-05
2022-12-31$15.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$30.19M
derived: sum of 2 quarters · filed 2025-03-05
$44.74M
derived: sum of 3 quarters · filed 2025-03-05
$57.90M
10-K · filed 2025-03-05
$59.38M
10-K · filed 2023-03-01
2022-09-30$15.12M
10-Q · filed 2023-11-07
$29.66M
derived: sum of 2 quarters · filed 2023-11-07
$42.83M
10-Q · filed 2023-11-07
$54.73M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30$14.55M
10-Q · filed 2023-08-01
$27.71M
10-Q · filed 2023-08-01
$39.61M
derived: sum of 3 quarters · filed 2024-03-08
$50.65M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31$13.17M
10-Q · filed 2023-05-02
$25.07M
derived: sum of 2 quarters · filed 2024-03-08
$36.10M
derived: sum of 3 quarters · filed 2024-03-08
$47.19M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31$11.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$22.93M
derived: sum of 2 quarters · filed 2024-03-08
$34.02M
derived: sum of 3 quarters · filed 2024-03-08
$46.06M
10-K · filed 2024-03-08
2021-09-30$11.03M
10-Q · filed 2022-11-01
$22.12M
derived: sum of 2 quarters · filed 2022-11-01
$34.16M
10-Q · filed 2022-11-01
$44.20M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$11.09M
10-Q · filed 2022-08-04
$23.13M
10-Q · filed 2022-08-04
$33.16M
derived: sum of 3 quarters · filed 2023-03-01
$42.99M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$12.04M
10-Q · filed 2022-05-05
$22.08M
derived: sum of 2 quarters · filed 2023-03-01
$31.90M
derived: sum of 3 quarters · filed 2023-03-01
$42.48M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$10.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$19.86M
derived: sum of 2 quarters · filed 2023-03-01
$30.44M
derived: sum of 3 quarters · filed 2023-03-01
$38.32M
10-K · filed 2023-03-01
2020-09-30$9.82M
10-Q · filed 2021-11-04
$20.40M
derived: sum of 2 quarters · filed 2021-11-04
$28.28M
10-Q · filed 2021-11-04
$35.50M
derived: sum of 4 quarters · filed 2022-03-03
2020-06-30$10.58M
10-Q · filed 2021-08-05
$18.46M
10-Q · filed 2021-08-05
$25.67M
derived: sum of 3 quarters · filed 2022-03-03
$32.94M
derived: sum of 4 quarters · filed 2022-03-03
2020-03-31$7.88M
10-Q · filed 2021-05-06
$15.10M
derived: sum of 2 quarters · filed 2022-03-03
$22.36M
derived: sum of 3 quarters · filed 2022-03-03
$28.93M
derived: sum of 4 quarters · filed 2022-03-03
2019-12-31$7.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$14.48M
derived: sum of 2 quarters · filed 2022-03-03
$21.05M
derived: sum of 3 quarters · filed 2022-03-03
$26.66M
10-K · filed 2022-03-03
2019-09-30$7.27M
10-Q · filed 2020-11-05
$13.84M
derived: sum of 2 quarters · filed 2020-11-05
$19.45M
10-Q · filed 2020-11-05
$23.99M
derived: sum of 4 quarters · filed 2021-03-11
2019-06-30$6.57M
10-Q · filed 2020-08-06
$12.18M
10-Q · filed 2020-08-06
$16.73M
derived: sum of 3 quarters · filed 2021-03-11
$21.60M
derived: sum of 4 quarters · filed 2021-03-11
2019-03-31$5.61M
10-Q · filed 2020-05-06
$10.16M
derived: sum of 2 quarters · filed 2021-03-11
$15.03M
derived: sum of 3 quarters · filed 2021-03-11
$20.53M
derived: sum of 4 quarters · filed 2021-03-11
2018-12-31$4.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$9.42M
derived: sum of 2 quarters · filed 2021-03-11
$14.92M
derived: sum of 3 quarters · filed 2021-03-11
$20.94M
10-K · filed 2021-03-11
2018-09-30$4.88M
10-Q · filed 2019-11-08
$10.38M
derived: sum of 2 quarters · filed 2019-11-08
$16.39M
10-Q · filed 2019-11-08
$23.08M
derived: sum of 4 quarters · filed 2020-03-05
2018-06-30$5.50M
10-Q · filed 2019-08-13
$11.52M
10-Q · filed 2019-08-13
$18.21M
derived: sum of 3 quarters · filed 2020-03-05
$21.69M
derived: sum of 4 quarters · filed 2020-03-05
2018-03-31$6.02M
10-Q · filed 2019-05-09
$12.71M
derived: sum of 2 quarters · filed 2020-03-05
$16.19M
derived: sum of 3 quarters · filed 2020-03-05
$19.62M
derived: sum of 4 quarters · filed 2020-03-05
2017-12-31$6.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
$10.18M
derived: sum of 2 quarters · filed 2020-03-05
$13.60M
derived: sum of 3 quarters · filed 2020-03-05
$16.97M
10-K · filed 2020-03-05
2017-09-30$3.49M
10-Q · filed 2018-10-31
$6.91M
derived: sum of 2 quarters · filed 2018-10-31
$10.28M
10-Q · filed 2018-10-31
$13.07M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$3.42M
10-Q · filed 2018-08-09
$6.79M
10-Q · filed 2018-08-09
$9.58M
derived: sum of 3 quarters · filed 2019-03-07
$12.47M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31$3.37M
10-Q · filed 2018-05-15
$6.16M
derived: sum of 2 quarters · filed 2019-03-07
$9.05M
derived: sum of 3 quarters · filed 2019-03-07
2016-12-31$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$5.68M
derived: sum of 2 quarters · filed 2019-03-07
$11.63M
10-K · filed 2019-03-07
2016-09-30$2.89M
10-Q · filed 2017-11-13
$8.84M
10-Q · filed 2017-11-13
2015-12-31$11.41M
10-K · filed 2018-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
CARLSMED, INC. (CARL)United States$0.405B